http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-553281-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccc16d4aab153443ba5ddab01e90b95d |
| filingDate | 2003-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c7c5c10d76d58ab1e02eff37668ad5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7536573a360281fba1e74fd11846c968 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_897a741bbe64cc6a3802c1c52cd91543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbaeac63e8f10f158165955c0076b49b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5532677fcd446106a7b6e82052c5a42 |
| publicationDate | 2009-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-553281-A |
| titleOfInvention | NT CNP Peptides and uses thereof |
| abstract | A method for assessing skeletal growth of a subject, comprising measuring the level of NT-CNP in a biological sample from the subject, and comparing the level against the mean NT-CNP level from a control population, wherein a significant difference in the measured NT-CNP level outside two standard deviations of the mean control level is indicative of abnormal skeletal growth in a patient not suffering from renal failure. (62) Divided Out of 526526 |
| priorityDate | 2003-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.